ImmuPharma PLC
ImmuPharma is a biopharmaceutical company that focuses on the development of biopolymers, specifically peptides. The company works on peptide-based therapeutic drugs targeting Autoimmunity/Inflammation and Anti-Infectives.
- BioAMB for fungal infections
- Peptide-based therapeutic drugs
- BioCIN for bacterial infections
- Lupuzor™ for Systemic Lupus Erythematosus (SLE)
- P140 for Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)